ReproCell Inc
TSE:4978
ReproCell Inc
Gross Profit
ReproCell Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ReproCell Inc
TSE:4978
|
Gross Profit
¥1.1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
|
GNI Group Ltd
TSE:2160
|
Gross Profit
¥22.4B
|
CAGR 3-Years
40%
|
CAGR 5-Years
40%
|
CAGR 10-Years
105%
|
|
PeptiDream Inc
TSE:4587
|
Gross Profit
¥17.2B
|
CAGR 3-Years
22%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Gross Profit
¥26.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Gross Profit
¥52B
|
CAGR 3-Years
29%
|
CAGR 5-Years
47%
|
CAGR 10-Years
49%
|
|
S
|
StemRIM Inc
TSE:4599
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ReproCell Inc's Gross Profit?
Gross Profit
1.1B
JPY
Based on the financial report for Dec 31, 2023, ReproCell Inc's Gross Profit amounts to 1.1B JPY.
What is ReproCell Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
16%
Over the last year, the Gross Profit growth was 0%. The average annual Gross Profit growth rates for ReproCell Inc have been 26% over the past three years , 18% over the past five years , and 16% over the past ten years .